Search

everythinglearnresearchcommunity

for

Search:↓

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

Standardized data is essential for diagnosing scalp and hair conditions in males.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Finasteride at 2.5mg/day may help postmenopausal women with hair loss.

The test and reference finasteride tablets are bioequivalent.

Both steroids, especially cyproterone acetate, harm quail's vital organs.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

A new accurate method was developed to measure Minoxidil and Aminexil in solutions.

NB-002 is a promising new topical treatment for fungal nail infections, showing better results than a non-medicated option.

Minoxidil and botulinum toxin are equally effective for treating female hair loss.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Increased ODC expression makes normally tumor-resistant mice more prone to tumor development.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

Finasteride improves hair density and thickness in women with hair loss.

Researchers developed a quick and reliable method to test for betamethasone dipropionate and calcipotriol in ointments and drugs.

Combined finasteride and spironolactone therapy significantly improves quality of life in women with PCOS.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Researchers created a reliable method to measure dexpanthenol and resorcinol in hair products.

88% phenol is effective for treating alopecia areata.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

Most adverse reactions to the treatment were mild, with nausea being the most common.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

5% topical minoxidil improves hair density and quality in monilethrix patients.